Related Experiment Video

Updated: Mar 27, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Protein kinase D1 inhibits breast cancer cell invasion via regulating matrix metalloproteinase expression

X J Qin, Z G Gao, J L Huan

    European Journal of Gynaecological Oncology
    |January 19, 2016
    PubMed
    Abstract

    Insights

    Protein kinase D1 (PKD1) is downregulated in invasive breast cancer. Reduced PKD1 expression correlates with increased matrix metalloproteinase (MMP) levels, suggesting PKD1

    Area of Science:

    • Oncology
    • Molecular Biology
    • Biochemistry

    Background:

    • Protein kinase D1 (PKD1) is a serine/threonine kinase implicated in various cellular processes.
    • Its role in breast cancer invasion and metastasis remains incompletely understood.

    Purpose of the Study:

    • To investigate the expression levels of PKD1 in invasive breast cancer tissues and cell lines.
    • To elucidate the functional role of PKD1 in regulating breast cancer cell invasion.

    Main Methods:

    • Quantitative analysis of PKD1 mRNA and protein expression in human breast cancer samples and cell lines.
    • Manipulation of PKD1 activity using constitutively-active constructs and short hairpin RNA (shRNA).
    • Assessment of matrix metalloproteinase (MMP) expression as a marker of invasive behavior.

    Main Results:

    • PKD1 expression was significantly downregulated in invasive and metastatic breast cancer tissues compared to normal tissues.
    • Low PKD1 expression was observed in invasive breast cancer cell lines, such as MD-MB-231.
    • Modulation of PKD1 levels inversely affected MMP2 and MMP9 expression, key regulators of invasion.

    Conclusions:

    • PKD1 downregulation is a characteristic feature of invasive breast cancer.
    • PKD1 negatively regulates MMP expression, suggesting an inhibitory role in cancer cell invasion.
    • PKD1 represents a potential therapeutic target for managing breast cancer metastasis.

    More Related Videos

    Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model08:08

    Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

    Published on: June 11, 2014

    16.5K
    An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

    An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

    Published on: June 30, 2015

    8.7K

    Related Concept Videos

    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    6.2K
    Inhibition of CDK Activity02:34

    Inhibition of CDK Activity

    5.6K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    5.1K
    The JAK-STAT Signaling Pathway01:20

    The JAK-STAT Signaling Pathway

    Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
    13.8K
    PI3K/mTOR/AKT Signaling Pathway01:22

    PI3K/mTOR/AKT Signaling Pathway

    The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
    6.3K
    Interactions Between Signaling Pathways01:19

    Interactions Between Signaling Pathways

    Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
    Convergence and divergence, and cross-talk between signaling pathways
    Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
    7.9K